Log in Open app

Yale Cancer Center

10.1K posts

Yale Cancer Center

@YaleCancer

Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.

New Haven, Connecticut

yalecancercenter.org

Joined September 2012

Yale Cancer Center
@YaleCancer
8h
.@Cecchini_OncMD joins #YaleCancerAnswers to talk about #colorectalcancer - explaining stages, treatment, and exciting research underway to improve outcomes. 🎧Listen live @wnpr 🔁Download via @ApplePodcasts, @Spotify 💻Listen later @YouTube @SmilowCancer @YaleGICancers
Yale Cancer Center
@YaleCancer
Aug 20
.@GeorgeGoshuaMD joined the Blood Podcast to discuss recent research in @BloodPortfolio: "Haploidentical transplant, gene therapy, and standard care in #sicklecelldisease: a cost-effectiveness analysis." bloodpodcast.transistor.fm/episodes/148-7 @SmilowCancer @YaleHematology
Yale Cancer Center
@YaleCancer
Aug 19
A new Phase 1 #clinicaltrial based on research led by Dr. Lieping Chen et al. showed B7-H3-targeting CAR-T cell therapy stopped growth or reduced #braintumor size for as long as 3 years post-treatment—including 1 participant whose #cancer remains in remission. #glioblastoma
medicine.yale.edu
T Cell Therapy Shows Promise in Treating Aggressive Brain Cancer
In a Phase I clinical trial, an immunotherapy stabilized or reduced tumors in several patients with treatment-resistant recurrent glioblastoma.
Yale Cancer Center
@YaleCancer
Aug 18
.@yalepathology is using an #AI platform to support #prostatecancer diagnoses. “It’s like a safety net to catch small things a pathologist may miss... but diagnosis remains with the pathologist,” says Dr. Joshua Warrick. medicine.yale.edu/cancer/news-ar… @SmilowCancer @Yale_Urology
medicine.yale.edu
Yale Pathology Using AI Platform to Support Prostate Cancer Diagnoses
Yale Pathology is using an AI platform to support prostate cancer diagnoses
Yale Cancer Center
@YaleCancer
Aug 17
.@MJGrantMD discusses his latest research on ERBB2-mutant lung cancer on the #JTOInsights podcast. Learn how activating mutations and co-occurring genomic alterations drive disease heterogeneity. jto.org/content/jto-in… @SmilowCancer @YaleThoracic